Skip to Main Content
Boston University
  • Bostonia
  • BU Today
  • The Brink
  • University Publications

    • Bostonia
    • BU Today
    • The Brink
  • School & College Publications

    • The Record
Other Publications
BU Today
  • Sections
News, Opinion, Community

Court ruling says Biosafety lab construction may continue

Ties completion to findings of further review

October 23, 2006
  • Art Jahnke
Twitter Facebook
The NEIDL is scheduled to be operational in the fall of 2008.

An effort to halt the funding and construction of the National Emerging Infectious Diseases Laboratories (NEIDL) being built by Boston University Medical Center was put on hold last Friday, when a federal judge ruled that construction can continue at least until an ongoing environmental review is completed. The decision, by U.S. District Judge Patti B. Saris, stated that it was not in the public interest to enjoin funding and construction of the $178 million Biosafety Level-4 lab at this time. The judge also rejected the plaintiffs’ effort to prevent BSL-2 and BSL-3 research from being conducted at the lab.

The lawsuit, brought by the Conservation Law Foundation (CLF), had asked the court to issue a preliminary injunction that would prevent the National Institutes of Public Health (NIH) from continuing to fund the project. The CLF argued that the federal government did not adequately investigate the risks of the lab or alternative locations for it before giving its final approval.

The October 20th decision ties the progress of the lab to further review of worst-case scenarios by the NIH, similar to those required by a separate state court ruling issued in July. Those reviews are expected to be completed in four to six months.  

Todd Klipp, general counsel for Boston University, described yesterday’s decision as a victory for the University. “We are confident that further studies will confirm that all relevant risks and worst-case scenarios have been considered,” said Klipp. “We believe they will show that the lab can be operated in a way that will present no danger to the surrounding neighborhood.”

The NEIDL will house a biosafety level 4 (BSL-4) lab for research on dangerous microorganisms, including Ebola and botulism. Because it will be located in a densely populated urban neighborhood, it has been a source of controversy ever since September 2003, when the NIH’s National Institutes of Allergy and Infectious Diseases (NIAID) awarded Boston University Medical Center $128 million to build the facility.

In response to safety concerns, Boston University officials stress that the lab will meet or exceed the strictest government security standards to protect researchers and the surrounding community. In addition to security personnel, metal detectors, and alarms, researchers entering the BSL-4 lab will first have to undergo a decontamination shower and don full-body hazardous materials suits. The pathogens themselves will be kept in liquid nitrogen containers that can be unlocked only with biometric or iris scans and pass codes from two researchers. All air flowing into and out of the building will pass through ultrafine HEPA filters capable of removing from the air microscopic particles of .3 microns or smaller. 

The Boston Redevelopment Authority Board gave its approval to the lab in December 2004, and the Boston Zoning Commission gave its approval in January 2005. BU officials estimate that the facility will create more than 1,300 construction jobs and more than 600 permanent jobs and that it will bring in $1.6 billion in federal research and construction grants over the next two decades.

For frequently asked questions about the NEIDL, click here. 

 

Explore Related Topics:

  • BUMC
  • Research
  • Share this story

Share

Court ruling says Biosafety lab construction may continue

Share

  • Twitter
  • Facebook
  • Reddit
  • LinkedIn
  • Email

Latest from BU Today

  • Education

    What’s Behind the Rise in Violence Against Teachers?

  • Fine Arts

    How I Made This: Jacob Whitchurch (CFA’26)

  • Things-to-do

    To Do Today: Seaport Sweat

  • Film & TV

    Did You Win Free Tickets to See Mission: Impossible—The Final Reckoning Tonight?

  • COMMENCEMENT 2025

    Experience BU’s 2025 Commencement from a Terrier Point of View

  • Obituaries

    Remembering Leslie Epstein, Pillar of BU’s Creative Writing Program

  • Voices & Opinion

    POV: This Memorial Day, Remember BU’s Fallen Heroes by Visiting the New Online Honor Wall

  • University News

    23 Charles River Campus Faculty Promoted to Full Professor

  • Commencement 2025

    Photos: A Look Back at BU’s Commencement

  • Theatre

    It’s “Prom Season” at Wheelock Family Theatre

  • Things-to-do

    Six Spots to Check Out This Memorial Day in Boston

  • Student Life

    Video: Class of 2025: What We’ll Take with Us as We Begin a New Chapter

  • Health & Medicine

    What Does Biden’s Cancer Diagnosis Mean?

  • Watch Now

    BU’s Class of 2025: What Are Your Plans After Graduating?

  • Fitness

    BU Sports Rehab Therapists on Jayson Tatum’s Achilles Injury and Recovery Ahead

  • Commencement 2025

    Sights and Sounds from Boston University’s Class of 2025 Commencement

  • Commencement 2025

    Video: 2025 Graduate Jayde Best: “I Ended Up Exactly Where I Wanted to Be”

  • Commencement 2025

    “Empathy Is Essential,” BU Commencement Speaker Emily Deschanel Tells 2025 Graduates

  • Voices & Opinion

    I’m a Business Professor Who Asked Dozens of Former Students How They Define Success

  • Commencement 2025

    Chobanian & Avedisian School of Medicine Convocations a Joyous Affair

Section navigation

  • Sections
  • Must Reads
  • Videos
  • Series
  • Close-ups
  • Archives
  • About + Contact
Get Our Email

Explore Our Publications

Bostonia

Boston University’s Alumni Magazine

BU Today

News, Opinion, Community

The Brink

Pioneering Research from Boston University

  • Twitter
  • Facebook
  • Youtube
  • LinkedIn
  • Instagram
  • Weibo
  • TikTok
© Boston University. All rights reserved. www.bu.edu
© 2025 Trustees of Boston UniversityPrivacy StatementAccessibility
Boston University
Notice of Non-Discrimination: Boston University prohibits discrimination and harassment on the basis of race, color, natural or protective hairstyle, religion, sex or gender, age, national origin, ethnicity, shared ancestry and ethnic characteristics, physical or mental disability, sexual orientation, gender identity and/or expression, genetic information, pregnancy or pregnancy-related condition, military service, marital, parental, veteran status, or any other legally protected status in any and all educational programs or activities operated by Boston University. Retaliation is also prohibited. Please refer questions or concerns about Title IX, discrimination based on any other status protected by law or BU policy, or retaliation to Boston University’s Executive Director of Equal Opportunity/Title IX Coordinator, at titleix@bu.edu or (617) 358-1796. Read Boston University’s full Notice of Nondiscrimination.
Search
Boston University Masterplate
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
Court ruling says Biosafety lab construction may continue
0
share this